Quick Answer
RHYTHM PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $3.11 (loss) per share for the year ending 2025.
- RHYTHM PHARMACEUTICALS, INC. showed an increase of +28.3% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from RHYTHM PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $0.78 (loss) per share | Q2 2020: $0.71 (loss) per share | Q1 2021: $0.90 per share | Q2 2021: $0.70 (loss) per share | Q3 2021: $0.70 (loss) per share | Q1 2022: $1.05 (loss) per share | Q2 2022: $0.89 (loss) per share | Q3 2022: $0.79 (loss) per share | Q1 2023: $0.92 (loss) per share | Q2 2023: $0.82 (loss) per share | Q3 2023: $0.76 (loss) per share | Q1 2024: $2.35 (loss) per share | Q2 2024: $0.55 (loss) per share | Q3 2024: $0.73 (loss) per share | Q1 2025: $0.81 (loss) per share | Q2 2025: $0.75 (loss) per share | Q3 2025: $0.82 (loss) per share.
- Over the full 7 years of available data (2019 to 2025), RHYTHM PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has grown by 19.4%.
- Historical annual values: Fiscal year 2025: $3.11 (loss) per share | Fiscal year 2024: $4.34 (loss) per share | Fiscal year 2023: $3.20 (loss) per share | Fiscal year 2022: $3.47 (loss) per share | Fiscal year 2021: $1.40 (loss) per share | Fiscal year 2020: $3.04 (loss) per share | Fiscal year 2019: $3.86 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: